Antifungal therapy – Page 12

A case of refractory onychomycosis caused by Kloeckera apiculata: Successful treatment with itraconazole

mycolabadmin

A 32-year-old man had a stubborn fungal nail infection caused by an extremely rare yeast called Kloeckera apiculata that didn’t respond to three different antifungal treatments over several years. After being identified through specialized laboratory testing including genetic sequencing, the infection was successfully cured with a 3-month course of the oral antifungal medication itraconazole. This case is notable because it is only the fourth known case of this rare fungal infection in humans and the first one to achieve complete cure with itraconazole treatment.

Shared Vision for Improving Outcomes for Serious Fungal Diseases: Report of a Patient, Caregiver, and Clinician Summit

mycolabadmin

Patients with serious fungal infections face significant challenges including long delays before diagnosis, substantial emotional and financial burden, and lasting effects on quality of life. A summit brought together patients, their caregivers, and fungal disease experts to share experiences and identify priorities for improving care. The group identified needs for better diagnostic tools, new treatments, improved medical education about fungal diseases, and patient support programs to help future patients and their families navigate fungal infections more effectively.

A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile

mycolabadmin

Researchers in Chile studied serious mold infections in 176 hospitalized patients (adults and children) over two years. They found that aspergillosis (a lung infection caused by Aspergillus mold) was the most common, especially in patients whose immune systems were compromised by cancer, transplants, or medications. Interestingly, nearly 40% of cases also involved COVID-19 infection. Although almost all patients received antifungal medications, survival rates were concerning, with about one-third of patients still alive after six months.

Paratracheal abscess by plant fungus Chondrostereum purpureum- first case report of human infection

mycolabadmin

A plant scientist in India developed an unusual infection caused by a fungus that normally only affects plants. The infection formed an abscess near his windpipe and caused voice problems and difficulty swallowing. Doctors couldn’t identify the fungus using standard methods, requiring DNA testing to confirm it was Chondrostereum purpureum, a fungus known to cause silver leaf disease in roses and other plants. The patient recovered completely after surgery to drain the abscess and antifungal medication for two months.

Trichosporon species bloodstream infections in a tertiary care hospital in the western region of Saudi Arabia: A 7-year retrospective chart review from 2016 to 2022

mycolabadmin

This study examined a rare but dangerous fungal infection called Trichosporonosis that affects the bloodstream in hospitalized patients. Researchers found that this infection kills about 60% of patients despite treatment with antifungal medications. The infection is often caused by a fungus called Trichosporon asahii and typically occurs in patients with weakened immune systems who are already hospitalized and using catheters.

Graphene nanomaterials: A new frontier in preventing respiratory fungal infections

mycolabadmin

Graphene nanomaterials, especially nano-graphene oxide, show promise as new treatments for serious lung fungal infections that particularly threaten people with weakened immune systems. These tiny materials work by generating damaging reactive oxygen species that kill fungal cells and prevent biofilm formation. Unlike traditional antifungal drugs, nano-graphene oxide can be delivered directly to infected lung tissue via inhalation, delivering medicine exactly where needed while reducing harmful side effects throughout the body.

Phaeoacremonium iranianum – a new corneal pathogen

mycolabadmin

A 66-year-old man developed a serious eye infection from a fungus called Phaeoacremonium iranianum after his eye was scratched by a leaf. This is the first reported case of this fungus causing a corneal infection. Doctors treated the infection with antifungal eye drops and surgery to remove infected tissue, and the patient’s condition improved over time, though with some permanent scarring of the cornea.

Odontogenic-onset mucormycosis: A case series from a tertiary care institute in North India

mycolabadmin

This study describes five cases of a serious fungal infection called mucormycosis that started in the mouth following dental procedures like tooth extraction. All patients had uncontrolled diabetes, which made them vulnerable to this infection. The infection was treated with antifungal medications and surgery, with good recovery. The findings highlight how important it is for dentists to follow strict hygiene practices and for diabetic patients to keep their blood sugar controlled before dental work.

Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review

mycolabadmin

This study examines rare fungal infections in patients with Chronic Granulomatous Disease, a genetic disorder affecting the immune system. Researchers found that these patients develop various unusual fungal infections despite taking preventive antifungal medications. The infections are difficult to diagnose, often requiring surgical procedures, but can sometimes be cured through stem cell transplantation combined with intensive antifungal treatment.

Schizophyllum commune infection following chimeric antigen receptor T-cell therapy in a patient with lymphoma

mycolabadmin

A 71-year-old woman receiving CAR T-cell therapy for lymphoma developed a rare fungal lung infection caused by Schizophyllum commune six months after treatment. The infection presented similarly to other fungal diseases affecting the lungs and was diagnosed through bronchoscopy and fungal culture despite negative blood antibody tests. Standard antifungal medication (voriconazole) taken by mouth for four months completely resolved the infection, highlighting the need to consider rare fungi in patients receiving advanced cancer immunotherapies.

Research Topic: Antifungal therapy